Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.35 USD | +3.21% | -1.42% | +52.37% |
18/04 | ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing | MT |
18/04 | ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- SPRY Stock
- Revisions ARS Pharmaceuticals, Inc.